According to Hong Kong Stock Exchange filings, BlackRock's stake in Hengrui Medicine's H shares decreased from 7.15% to 6.96% on September 24, with the average selling price at HK$47.481.
2026-09-29
According to Hong Kong Stock Exchange filings, BlackRock's stake in Hengrui Medicine's H shares decreased from 7.15% to 6.96% on September 24, with the average selling price at HK$47.481.